R. H. BROOKS, M.D.; H. B. CALLEJA, M.D.
The last decade has seen universal acceptance of anticoagulant therapy in thromboembolic diseases. In the treatment of individual cases, however, particularly those of acute coronary occlusion, opinion varies as to which cases should receive anticoagulants, and how long therapy should be continued. In addition, hemorrhage is generally accepted as a calculated risk directly attributable to the very nature of the therapy, regardless of the type and kind of anticoagulant used. Indeed, fatal hemorrhagic complications have occurred. Cautious, close supervision of the patient, better knowledge of the type of drug used, and due respect for established contraindications must be emphasized if
Learn more about subscription options.
Register Now for a free account.
BROOKS RH, CALLEJA HB. DERMATITIS, HEPATITIS AND NEPHRITIS DUE TO PHENINDIONE (PHENYLINDANDIONE)(DERMATITIS, HEPATITIS AND NEPHRITIS DUE TO PHENINDIONE (PHENYLINDANDIONE)*). Ann Intern Med. 1960;52:706–710. doi: 10.7326/0003-4819-52-3-706
Download citation file:
Published: Ann Intern Med. 1960;52(3):706-710.
Gastroenterology/Hepatology, Liver Disease, Nephrology.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only